APM
DVAX

Avidity Partners Management’s Dynavax Technologies DVAX Stock Holding History

Avidity Partners Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,400,000
Closed -$33.5M – 116
2021
Q2 		$33.5M Sell
3,400,000
-100,000
-3% -$909K 0.91% 40
2021
Q1 		$34.4M Sell
3,500,000
-500,000
-13% -$4.12M 0.96% 39
2020
Q4 		$17.8M Buy
4,000,000
+1,975,000
+98% +$8.94M 0.6% 51
2020
Q3 		$8.75M Sell
2,025,000
-649,154
-24% -$4.63M 0.47% 48
2020
Q2 		$23.7M Sell
2,674,154
-1,149,846
-30% -$5.81M 1.52% 23
2020
Q1 		$13.5M Buy
3,824,000
+3,044,000
+390% +$14.1M 1.94% 22
2019
Q4 		$4.46M Buy
+780,000
New +$4.17M 2.81% 16

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return